Provident Financial Services, Inc. — News

Does Provident Financial (PFS) have what it takes to be a top stock pick for momentum investors? Let's find out.

zacks.com - 2026-08-05 13:01:23

Total Product Sales (excluding Veklury): $7.6 billion, up 10% year-over-year.Total Product Sales (including Veklury): $7.6 billion, up 8% year-over-year.HIV Sal

gurufocus.com - 2026-08-05 00:06:00

Experienced finance leader assumes expanded role overseeing accounting strategy and financial reporting Experienced finance leader assumes expanded role overseeing accounting strategy and financial reporting

globenewswire.com - 2026-08-04 16:30:00

ISELIN, N.J., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) (the "Company") announced today that Michael E. Regan has been appointed to the boards of directors of the Company and its wholly owned subsidiary, Provident Bank, effective July 30, 2026.

globenewswire.com - 2026-08-04 14:00:00

Provident Financial Services remains a 'Hold' after strong Q2 results and a 25% stock gain over the past year. PFS benefits from robust loan growth, successful Lakeland integration, and expanding fee income but faces rising deposit costs and competitive funding pressures. Credit quality is solid with low charge-offs and manageable NPLs; reserve coverage appears sufficient even with senior housing exposure.

seekingalpha.com - 2026-08-03 07:00:00

Provident Financial Services NYSE: PFS reported second-quarter net earnings of $78 million, or $0.60 per diluted share, while core net earnings totaled $80 million, or $0.61 per share. President and CEO Anthony Labozzetta said earnings per share for the first half of 2026 increased 17% from the prior-year period as the company recorded higher net interest income and non-interest income.

marketbeat.com - 2026-07-31 20:05:35

Provident Financial Services, Inc. (PFS) Q2 2026 Earnings Call Transcript

seekingalpha.com - 2026-07-30 21:33:13

ISELIN, N.J., July 30, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) Board of Directors declared a quarterly cash dividend of $0.24 per common share payable on August 28, 2026 to stockholders of record as of the close of business on August 14, 2026.

globenewswire.com - 2026-07-30 16:30:00

Vancouver, British Columbia, July 30, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV:  SURG ) (OTCQB: SRGXF ) (Frankfurt: G6D2 ) (“Surge” or the “Company”) is pleased to announce that it has filed a technical report titled “Berg Copper Project NI 43-101 Technical Report and Pre-Feasibility Study” (the “Technical Report”), prepared in accordance with National Instrument 43-101 – Standards of Disclosure for Mineral Projects. The Technical Report supports the Company's  June 15, 2026 news release announcing the results of the Pre-Feasibility Study (“PFS”) for the Berg Copper Project (“Berg” or the “Project”), located in central British Columbia. The Technical Report is available under the Company's profile on SEDAR+ at www.sedarplus.ca and on the Company's website at www.surgecopper.com . The Technical Report, prepared by Ausenco Engineering Canada ULC (“Ausenco”) and Moose Mountain Technical Services Inc. (“MMTS”), provides the detailed technical basis for the PFS and includes additional discussion of metallurgical optimization, mine-planning trade-offs and the recommended work programs for advancing the Project toward feasibility-level engineering and environmental assessment, as highlighted below. Leif Nilsson, Chief Executive Officer, commented: “The Berg PFS Technical Report is an important technical disclosure document that will support the continued advancement of the Berg Copper Project toward feasibility-level engineering and environmental assessment. Furthermore, it provides the detailed technical basis and broader context for the work underpinning the PFS. We would like to thank the teams at Ausenco and Moose Mountain for the exceptional quality of their work and their contribution to this important milestone for the Project”. PFS Highlights For ease of reference, selected highlights of the Berg PFS previously announced by the Company on June 15, 2026 are summarized below. The following information is abridged and should be read in conjunction with the June 15, 2026 news release and the Technical Report, which contain the complete disclosure supporting these highlights, including the assumptions, qualifications and other information relating to the Mineral Reserve estimate and PFS results.

globenewswire.com - 2026-07-30 07:00:00

Although the revenue and EPS for Provident Financial (PFS) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

zacks.com - 2026-07-29 20:31:07

Provident Financial (PFS) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.55 per share a year ago.

zacks.com - 2026-07-29 19:26:13

ISELIN, N.J., July 29, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE:PFS) (the “Company”) reported net income of $78.1 million, or $0.60 per basic and diluted share for the three months ended June 30, 2026, compared to $79.4 million, or $0.61 per basic and diluted share, for the three months ended March 31, 2026 and $72.0 million, or $0.55 per basic and diluted share, for the three months ended June 30, 2025. For the six months ended June 30, 2026, net income totaled $157.6 million, or $1.21 per basic and diluted share, compared to $136.0 million, or $1.04 per basic and diluted share, for the six months ended June 30, 2025. For the three and six months ended June 30, 2026, core net income (1), which has been adjusted for one-time core system conversion and executive severance expenses, totaled $79.9 million, or $0.61 per basic and diluted share and $159.3 million, or $1.22 per basic and diluted share, respectively.

globenewswire.com - 2026-07-29 16:30:00

REGN INVESTOR ALERT: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Regeneron Class Action Lawsuit -

gurufocus.com - 2026-07-29 14:00:00

Positive high-level results from the CLARITY-Gastric01 global Phase III trial showed that sonesitatug vedotin (Sone-Ve) demonstrated a statistically significan

gurufocus.com - 2026-07-27 08:00:00

Funding is provided through the FHLBNY Small Business Recovery Grant Program Funding is provided through the FHLBNY Small Business Recovery Grant Program

globenewswire.com - 2026-07-22 08:00:00

Inhibrx is transitioning from a platform to a clinical-stage biotech, with ozekibart and INBRX-106 as key value drivers. Ozekibart's BLA for chondrosarcoma is under FDA review with an April 14, 2027 PDUFA date, supported by strong PFS and disease control data. INBRX-106 shows promising early efficacy as a PD-1 enhancer in HNSCC, with pivotal PFS data expected in Q4 2026 and Phase 3 initiation in Q3 2026.

seekingalpha.com - 2026-07-17 06:43:05

ISELIN, N.J., July 15, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today that Anthony Petrazzuoli has joined the bank as Senior Vice President, Deposit & Payments Operations Director.

globenewswire.com - 2026-07-15 08:00:00

WHITE SULPHUR SPRINGS, Mont., July 09, 2026 (GLOBE NEWSWIRE) -- Sandfire Resources America Inc. ("Sandfire America" or the "Company") is pleased to announce the results of an updated Preliminary Feasibility Study ("PFS") for the Black Butte Copper Project (the “Project” or “Black Butte Copper”) that significantly enhances the Project's long-term value through the inclusion of the nearby Lowry copper deposit (the "Lowry Deposit") in the mine plan. The updated PFS results position the Black Butte Copper Project as one of the highest-grade undeveloped underground copper projects in the United States.

globenewswire.com - 2026-07-09 05:00:00

ISELIN, N.J., July 01, 2026 (GLOBE NEWSWIRE) -- Provident Financial Services, Inc. (NYSE: PFS) announced that it expects to release financial results for the quarter ended June 30, 2026 on Wednesday, July 29, 2026 after market close. A copy of the earnings release will be immediately available on the Company's website, www.Provident.Bank, by going to Investor Relations and clicking on Press Releases.

globenewswire.com - 2026-07-01 10:32:00

Toronto, Ontario--(Newsfile Corp. - June 25, 2026) - Tartisan Nickel Corp. (CSE: TN) (OTCQX: TTSRF) (FSE: 8TA) ("Tartisan", or the "Company") is pleased to announce that it has engaged Tetra Tech⁠ Canada Inc. (Tetra Tech) to conduct an independent review of the existing Preliminary Economic Assessment (PEA) for the Kenbridge Nickel-Copper-Cobalt Project and deliver a structured Goal-Actual-Plan Analysis (GAP) identifying the technical, commercial, and compliance work required to advance the Kenbridge Project to the Pre-Feasibility Study (PFS) level. The Tetra Tech Team will preform a PFS GAP Analysis and prepare a Technical Memorandum for Tartisan's Internal use that includes the outcomes of the following services: Assess the quality, completeness and assumptions of the current PEA Identify gaps relative to PFS requirements (technical, data, and test work) Prioritise gaps and recommend a staged work program with cost/time estimates to close them.

newsfilecorp.com - 2026-06-25 07:50:00

Pfizer Inc. (NYSE: PFE) today announced the U.S. Food and Drug Administration (FDA) approved IBRANCEÂ (palbociclib) in combination with trastuzumab, with or w

gurufocus.com - 2026-06-24 15:00:00

Today, American Ocean Minerals Corporation (AOMC) announced the successful completion of Expedition 7, a research campaign designed to support the environmenta

gurufocus.com - 2026-06-24 10:00:00

ISELIN, N.J., June 23, 2026 (GLOBE NEWSWIRE) -- Provident Bank, a leading New Jersey-based financial institution, announced today the appointment of Adriano Duarte to Executive Vice President and Chief Financial Officer of Provident Bank and Provident Financial Services, Inc. (NYSE: PFS), effective July 1, 2026.

globenewswire.com - 2026-06-23 08:00:00

AbbVie Announces European Commission Approval of SKYRIZIÂ (risankizumab) for the Treatment of Pediatric Patients with Moderate to Severe Plaqu

gurufocus.com - 2026-06-23 04:00:00

Expanded programs targeting Q1 CY27 completion & ML application HIGHLIGHTS GR Engineering appointed to lead Pre-feasibility Study (PFS) for Tunkillia Gold Project; targeting Q1 CY27 PFS completion to include prospective Resource upside in open pit optimisations Ongoing upgrade drilling has already infilled highest value ‘S1' and ‘S2' optimised open pit areas with broad, high-grade mineralisation and identified higher-grade extensions of ‘Area 51' open pit area; Phase 2 drilling has now expanded, targeting Resources and grade upside mineralisation in open pits[1] ADELAIDE, AUSTRALIA / ACCESS Newswire / June 21, 2026 / Barton Gold Holdings Limited (ASX:BGD)(OTCQB:BGDFF)(FRA:BGD3) (Barton or Company) is pleased to announce that a Pre-Feasibility Study (PFS) has started for its South Australian Tunkillia Gold Project (Tunkillia). GR Engineering Services Limited (GRES) has been appointed to lead the PFS.

accessnewswire.com - 2026-06-21 21:00:00

Funds will be used to support revitalization plans for distressed neighborhoods Funds will be used to support revitalization plans for distressed neighborhoods

globenewswire.com - 2026-06-17 08:00:00

Lilly's Jaypirca (pirtobrutinib) significantly reduced the risk of disease progression or death by 45% when added to a venetoclax time-limited

gurufocus.com - 2026-06-14 04:00:00

[url="]Genmab A/S[/url] (Nasdaq: GMAB) today announced new data from two studies evaluating epcoritamab, a T-cell engaging antibody administered subcutaneously

gurufocus.com - 2026-06-13 13:00:00

New TALVEYÂ (talquetamab-tgvs) plus DARZALEX FASPROÂ (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combi

gurufocus.com - 2026-06-13 07:00:00

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min

gurufocus.com - 2026-06-13 06:00:00

[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 datas

gurufocus.com - 2026-06-11 08:00:00

[url="]The Schall Law Firm[/url], a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Regeneron P

gurufocus.com - 2026-06-10 16:00:00

WuXi Biologics Singapore CRDMO Hub Completes Modular Topping-Out of Drug Product Facility PR Newswire SINGAPORE,

gurufocus.com - 2026-06-04 23:00:00

Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management Business Seasoned Wealth Management Executive to Lead Strategic Growth of Provident Bank's Wealth Management Business

globenewswire.com - 2026-06-04 08:00:00

Further positive results from the Phase III SERENA-6 trial showed AstraZeneca's camizestrant plus a cyclin-dependent kinase (CDK) 4/6 inhibitor – palbociclib

gurufocus.com - 2026-06-02 09:00:00

IDEAYA Biosciences and Servier Provide Complete Data from Phase 2/3 Registrational OptimUM-02 Trial of the Darovasertib Combination in First Li

gurufocus.com - 2026-06-01 12:00:00

Hengrui Pharma Presents More Than 90 Oncology Studies at ASCO 2026, Highlighting Progress Across Multiple Tumor Types PR Newswi

gurufocus.com - 2026-06-01 02:00:00

Summit Therapeutics Inc. (NASDAQ: SMMT) today announced positive overall survival (OS) results from the Phase III HARMONi-6 trial, conducted in China and spons

gurufocus.com - 2026-05-31 10:00:00

[url="]Pfizer Inc. [/url](NYSE: PFE) today announced detailed progression-free and overall survival results from Cohort 3, a randomized cohort of the Phase 3 B

gurufocus.com - 2026-05-31 09:00:00

Dizal Presents Positive NSCLC Data for Fourth-Generation EGFR TKI DZD6008 and Golidocitinib in Combination with Anti-PD-1 at ASCO 2026

gurufocus.com - 2026-05-30 21:00:00

[url="]Exelixis, Inc.[/url] (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYXÂ

gurufocus.com - 2026-05-30 11:00:00

[url="]Immunome, Inc.[/url] (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today a

gurufocus.com - 2026-05-30 09:00:00

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in

gurufocus.com - 2026-05-30 09:00:00

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (MonjuviÂ/Min

gurufocus.com - 2026-05-30 09:00:00

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the latest results from its missi

gurufocus.com - 2026-05-29 10:00:00

[url="]BeOne Medicines Ltd.[/url] (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocyti

gurufocus.com - 2026-05-29 07:00:00

ISELIN, N.J., May 27, 2026 (GLOBE NEWSWIRE) -- Provident Bank , a leading New Jersey-based financial institution has announced that Jessica Dudick has been promoted to Senior Vice President, Team Leader with the bank's Monmouth/Ocean C&I lending team.

globenewswire.com - 2026-05-27 08:00:00

WuXi Biologics Achieves GMP Release of 18th Drug Product Facility, Advancing Integrated Drug Substance to Drug Product Capabilities

gurufocus.com - 2026-05-27 06:00:00

Black Diamond Therapeutics NASDAQ: BDTX reported updated Phase 2 data for silevertinib in treatment-naive non-small cell lung cancer patients with EGFR Non-Classical Mutations, saying the investigational therapy produced a preliminary median progression-free survival of 15.2 months in the study cohort.

marketbeat.com - 2026-05-21 19:09:20

ImmunityBio, Inc. ([url="]NASDAQ: IBRX[/url]), a commercial-stage immunotherapy company, today announced that the U.S. Food and Drug Administration has accepte

gurufocus.com - 2026-05-19 21:00:00